Photonamic acquires MolecuLight's clinical oncology business

Photonamic GmbH & Co. KG acquired the clinical oncology business of Toronto-based MolecuLight. The two businesses will form a subsidiary called SBI ALApharma Canada, combining MolecuLight's fluorescence imaging technology with Photonamic's 5-ALA contrast agent.

“We are thrilled to announce the acquisition of our clinical oncology business by such a valued and strategic partner as Photonamic.”betakit.com

• 1 source
• betakit.comMolecuLight's oncology business acquired by Germany-based Photonamic | BetaKitIsabelle KirkwoodAug 15, 2019

Summarized from public sources; check the original articles before acting on it.